A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC
Open Access
- 25 November 2022
- journal article
- research article
- Published by Springer Nature in Nature Cancer
- Vol. 3 (11) , 1300-1317
Abstract
Five-year survival for human papilloma virus-unrelated head and neck squamous cell carcinomas remain below 50%. We assessed the safety of administering combination hypofractionated stereotactic body radiation therapy with single-dose durvalumab (anti-PD-L1) neoadjuvantly (n = 21) (NCT03635164). The primary endpoint of the study was safety, which was met. Secondary endpoints included radiographic, pathologic and objective response; locoregional control; progression-free survival; and overall survival. Among evaluable patients at an early median follow-up of 16 months (448 d or 64 weeks), overall survival was 80.1% with 95% confidence interval (95% CI) (62.0%, 100.0%), locoregional control and progression-free survival were 75.8% with 95% CI (57.5%, 99.8%), and major pathological response or complete response was 75% with 95% exact CI (51.6%, 100.0%). For patients treated with 24 Gy, 89% with 95% CI (57.1%, 100.0%) had MPR or CR. Using high-dimensional multi-omics and spatial data as well as biological correlatives, we show that responders had: (1) an increase in effector T cells; (2) a decrease in immunosuppressive cells; and (3) an increase in antigen presentation post-treatment.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (F31 DE029997, 1R01DE028282-01, 1R01DE028529-01)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (1P50CA261605-01)
This publication has 69 references indexed in Scilit:
- Harnessing the Heterogeneity of T Cell Differentiation Fate to Fine-Tune Generation of Effector and Memory T CellsFrontiers in Immunology, 2014
- Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydrataseNature, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumorsProceedings of the National Academy of Sciences, 2011
- Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and InterpretationPLOS ONE, 2010
- Missing data imputation using statistical and machine learning methods in a real breast cancer problemArtificial Intelligence in Medicine, 2010
- MHC II lung cancer vaccines prime and boost tumor‐specific CD4 + T cells that cross‐react with multiple histologic subtypes of nonsmall cell lung cancer cellsInternational Journal of Cancer, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatmentBlood, 2009
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003